Navigation Links
Diabetes a risk factor for postpartum depression
Date:2/24/2009

BOSTON, Mass. (Feb 23, 2009) Postpartum depression is a seriousand often undiagnosedcondition affecting about 10 to 12 percent of new mothers. Some of the causes might include personal history of depression, stressful life events, and lack of social, financial or emotional support. Left untreated, it can have lasting negative effects not only on the mother but on her child's development.

In the first study of its kind, investigators at Harvard Medical School and the University of Minnesota School of Public Health report that low-income women with diabetes have a more than 50% increased risk of experiencing this serious illness.

"While previous studies have linked diabetes and depression in the general population, this is the first time, to our knowledge, that the relationship has been studied specifically in pregnant women and new mothers," says Katy Backes Kozhimannil, research fellow in the Department of Ambulatory Care and Prevention at Harvard Medical School and Harvard Pilgrim Health Care. "We believe these findings may help clinicians better identify and treat depression in new mothers."

These findings are published in the February 25 edition of JAMA, the Journal of the American Medical Association.

For over 25 years, clinicians have been aware that new mothers are at risk for postpartum depression. However, the condition is difficult to identify. Many symptoms are attributed to the every-day struggles of being a new mother. Others, such as irrational thoughts about harming the baby or, conversely, obsessing over the baby's health, are simply difficult for new mothers to admit.

To investigate the potential link between diabetes and postpartum depression, Kozhimannil and Bernard Harlow, professor in the University of Minnesota's School of Public Health, examined medical claims data from the New Jersey Medicaid program, looking at information from 11,024 new mothers who had given birth between
'/>"/>

Contact: David Cameron
david_cameron@hms.harvard.edu
617-432-0441
Harvard Medical School
Source:Eurekalert

0

GOOD

Page: 1 2

Related medicine news :

1. Diabetes Linked to Depression During and After Pregnancy
2. Pennsylvanians May Donate Part of Tax Refund to Support Juvenile Diabetes Research
3. Grammy-nominated Singer Angie Stone Encourages African-Americans in Birmingham to Fearlessly FACE Diabetes
4. One in Five Augustans With Type 2 Diabetes Mistakenly Believe That Being Obese or Overweight Can Positively Impact Their Disease
5. LSUHSC research may benefit diabetes by increasing understanding of how to control islet cell growth
6. Novo Nordisk Appoints Andy Ajello as Vice President for National Diabetes Sales, Managed Care and Government Accounts
7. GSK Initiates Phase III Programme for Novel Type 2 Diabetes Medication, Syncria(R) (albiglutide)
8. Cardiovascular Disease and Diabetes: New Blog and Slide Presentation on the Diabetes Best Practices Website Discuss the Most Recent Studies in this Field
9. PDHI Adds Diabetes and Heart Disease Prevention to ConXus Steps Library of Action Plans
10. Arete Therapeutics Initiates Phase IIa Clinical Trial for AR9281, a Novel s-EH Inhibitor to Treat Type 2 Diabetes
11. Roche Announces Significant Price Reduction of Two ACCU-CHEK(R) Glucose Monitoring Kits to Help Customers With Diabetes During These Difficult Economic Times
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... Neurological Stress Reduction Therapy or NSRTSM is found very effective ... such as allergies, asthma, migraines, chronic fatigue and a wide ... the country are using this holistic therapy including over 50 ... ... Allentown, PA (Vocus) December 16, 2009 -- BioVeda ...
(Date:12/16/2009)... -- If proposed health care legislation is enacted, ... insurance system. Approximately 18.4 million Californians and 161 ... upon employer-based insurance for their health care coverage. ... reform legislation entail specific requirements for employer-based insurance. ... for firms that currently comply with most new ...
(Date:12/16/2009)... 16 New Enterprise Associates, Inc. (NEA), ... that one of its portfolio companies, Acclarent, Inc., ... acquired by Ethicon, Inc., a Johnson & Johnson ... million (net of estimated cash on hand at ... to designing, developing and commercializing devices that address ...
(Date:12/16/2009)... -- Allscripts (Nasdaq: MDRX ) announced today ... the three and six months ended November 30, ... January 11, 2010. Allscripts management will host a ... earnings and other information at 8:30 AM Eastern ... http://www.newscom.com/cgi-bin/prnh/20081013/AQM041LOGO ) ,, Allscripts fiscal second quarter ...
(Date:12/16/2009)... Averting second, possibly deadly, attack is long-term goal, researchers ... Researchers have developed a tool to predict whether a ... of a first stroke. , "This is an important ... have a second stroke soon after a first stroke ... Dr. Hakan Ay, of Massachusetts General Hospital and Harvard ...
Breaking Medicine News(10 mins):Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 2Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 3Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 4Health News:BioVeda Health and Wellness Center of Allentown, PA Announces Its Grand Opening 5Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 2Health News:How National Health Reform Proposals Would Affect Employer-Based Plans in California 3Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 2Health News:NEA-Incubated Acclarent Acquired by Johnson & Johnson's Ethicon 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 2Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 3Health News:Allscripts to Announce Second Quarter Fiscal 2010 Results 4Health News:New Stroke Tool May Predict Early Recurrence 2
... have asked the World Health Organization to investigate the possibility ... of bird flu//. They are already ready to invest $1.9bn ... virus is already being done. ,Tony Blair while ... preparedness for an outbreak of bird flu insisted that precautions ...
... of neurobiology at the University of California, Irvine (UCI) ... that the experimental drug// AF267B is effective against both ... mice. ,This compound (AF267B) curbs both the ... well as another lesion, the tangles of protein called ...
... PhD, of the University of Reading in England, has said ... or antiperspirants and breast cancer. She says that he aluminum-based ... body.// ,"Lifetime exposure to estrogen is the risk ... said. "If the aluminum salts in antiperspirants enter the body ...
... as about 3,000 people in the steel town were affected by ... in a small group at a slum// cluster in Panposh on ... then, it has rapidly spread to other parts of the town. ... acute colic pain, said a senior district health official. ...
... A research team has now established that a delayed-release ... may be associated with less abuse, when compared to ... the form of an oral formulation have not been ... drug abuse. The results of the study can be ...
... For those who instantly saw it as a half full glass, ... your body will promote overall well-being// and also lower cardiovascular risk ... men in the age group of 64 to 84, the most ... and demeanor had been tracked for nearly 15 years. This study ...
Other Medicine News:Health News:Experimental Alzheimer’s Drug curbs the disease in mic 2Health News:Concerta, Drug Used in ADHD Treatment Less Likely To Result In Abuse 2
(Date:12/16/2009)... Dec. 16 Medlytix, a national healthcare ... a key half-billion dollar milestone - the total ... provided in financial assistance to more than a ... of properly classifying charity care - in less ... of these hospitals enhanced their bottom lines and ...
(Date:12/16/2009)... 16 Ethicon, Inc., a Johnson & ... a worldwide leader in surgical care, and Acclarent, ... to designing, developing and commercializing devices that address ... today announced a definitive merger agreement whereby Ethicon ... approximately $785 million net of estimated cash on ...
(Date:12/16/2009)... 16 Hospira, Inc. (NYSE: HSP ... company, today announced that it will host a conference ... and projections for 2010 on Thursday, Feb. 4, 2010, ... release its fourth-quarter and full-year 2009 results earlier that ... conference call. ,, A live webcast of the conference ...
Breaking Medicine Technology:Healthcare Scoring System Allows Hospitals To Increase Charity Care 2Healthcare Scoring System Allows Hospitals To Increase Charity Care 3Healthcare Scoring System Allows Hospitals To Increase Charity Care 4Ethicon Announces Definitive Agreement to Acquire Acclarent 2Ethicon Announces Definitive Agreement to Acquire Acclarent 3Ethicon Announces Definitive Agreement to Acquire Acclarent 4Dee Snider Leads 2009 March of Dimes Bikers for Babies 28R 29 48644 1Dee Snider Leads 2009 March of Dimes Bikers for Babies 28R 29 48644 2Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award 48641 1Oncology Program at Texas Health Dallas Receives Outstanding Achievement Award 48641 2Protein Branded As Culprit in Mad Cow Disease 48638 1Protein Branded As Culprit in Mad Cow Disease 48638 2
... The Society of Gynecologic Oncologists (SGO) and the American ... a breast disease fellowship training program for gynecologic oncologists. ... the program provides support for a gynecologic oncologist to ... treatment of breast cancer and related disease. "As ...
... today announced that it has received clearance from ... the U.K. Medicines and Healthcare products Regulatory Agency ... AeroTrial(TM), of inhaled dry powder Aerovant in patients ... United States for AeroTrial, a double-blind, randomized, placebo-controlled, ...
Other Medicine Technology:SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists 2SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists 3Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma 2Aerovance Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: